Related Experiment Video
Updated: May 6, 2026
07:06
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
26.7K
Editorial: PPIs and recurrent C. difficile infection: no association?
1Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
The American Journal of Gastroenterology
|November 7, 2013
Summary
Proton-pump inhibitors (PPIs) do not appear to increase the risk of recurrent Clostridium difficile infection in hospitalized patients, according to a new cohort study. This finding challenges previous research, highlighting the need for appropriate PPI use.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Pharmacology
Background:
- Proton-pump inhibitors (PPIs) are widely used for acid-related gastrointestinal disorders.
- Previous studies suggested a link between PPI use and recurrent Clostridium difficile infection (CDI).
- Concerns exist regarding the potential for PPIs to increase CDI recurrence risk in hospitalized patients.
Discussion:
- A rigorous cohort study investigated the association between PPI use and recurrent CDI in hospitalized patients.
- The study found no statistically significant association between PPI use and recurrent CDI.
- This contrasts with earlier research, which may have been limited by bias.
Key Insights:
- Appropriate use of proton-pump inhibitors is crucial, irrespective of their association with Clostridium difficile infection.
- Hospitalized patients on proton-pump inhibitors are not at increased risk for recurrent Clostridium difficile infection.
- This study provides robust evidence challenging previous findings on PPIs and CDI recurrence.
Outlook:
- Further research may be needed to fully elucidate the complex relationship between PPIs and Clostridium difficile infection.
- Clinical guidelines should emphasize judicious PPI prescribing to minimize potential risks.
- Understanding the factors influencing Clostridium difficile infection recurrence remains a priority in patient care.
Related Concept Videos
01:22Healthcare Associated Infections II: Preventive Measures
4.7K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.7K
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
5.8K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
5.8K
01:25Inflammatory Bowel Disease III: Crohn's Disease
75
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
75
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
866
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
866
01:17Transmission-based Precautions I: Contact, Enteric, and Droplets
5.1K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
5.1K
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
61
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
61